期刊文献+

不同血压水平与转甲状腺素蛋白的关系研究 被引量:1

The Relationship between Transthyretin and the Level of Blood Pressure
下载PDF
导出
摘要 目的探讨高血压患者转甲状腺素蛋白(transthyretin,TTR)的水平及其与血压的关系。方法在流行病学调查中将调查对象分为正常组、高血压前期组和高血压组。对所调查对象测量人体测量学指标,进行75g口服葡萄糖耐量试验,测定血脂、血糖、胰岛素和TTR等。结果①3组TTR水平分别为(321.5±4.5)、(335.1±3.6)与(354.6±4.2)mg/L,3组间差异有显著性(P<0.01);进一步校正年龄、性别、BMI、WHR、WC和HOMA-IR后,高血压组与正常组和高血压前期组相比差异仍有显著性(P均<0.01),正常组与高血压前期组之间无显著性差异(P>0.05)。②校正年龄、性别因素后,TTR与SBP和DBP相关系数分别为0.1617、0.1708,P均<0.01;进一步校正年龄、性别、BMI、WC、HOMA-IR后,TTR与SBP和DBP的相关系数为0.1515、0.1670,P均<0.01。③多元逐步回归分析显示,影响血压的主要因素是BMI、WC、TTR、HOMA-IR和年龄。结论高血压患者存在不同程度的TTR水平的升高,高血压前期患者亦存在相似的变化,血压与TTR的关系不依赖于体脂参数、胰岛素抵抗等相关因素,血压与TTR的关系有待进一步研究。 Objective To explore the level of transthyretin(TTR) in hypertensive patients and the relationship between TTR and blood pressure. Methods Seventy-five gram oral glucose tolerance tests were conducted, somatometry parameters, lipid-profile, blood glucose, insulin and TTR were assayed. They were divided into control group, pre-hypertensive group and hypertensive group. Results ①The concentration of TTR in three groups had significant difference[(321.5± 4.5)mg/L, (335.1±3.6) mg/L, (354.6±4.2) mg/L,P〈0.01]. Rejecting the age,gender,BMI, WHR,WC and HOMA-IR, there was significant difference between hypertensive group and either control group or pre-hypertensive group(all P〈0.01) ,but there was no significant difference between control group and pre-hypertensive group(all P〉0.05). ②Rejecting the age, gender,the coefficient correlation between TTR,SBP and DBP were 0. 161 7.0. 170 8(P〈0.01). Then Rejecting the age and gender,BMI,WC, HOMA-IR, the coefficient correlation between TTR, SBP and DBP were 0. 151 5.0. 167 0(all P〈0.01). ③Muhielement stepwise regression analysis suggest that BMI,WC,TTR, HOMA-Ir and age were major factors to regulate the level of blood pressure. Conclusion There is increased TTR no matter blood presure level in hypertentive patients, so is the similar situation in pre-hypertensive patients. The relationship between blood pressure and TTR does not rely body fat parameter and IR,and it need to further study.
出处 《江西医学院学报》 2008年第3期40-42,48,共4页 Acta Academiae Medicinae Jiangxi
基金 国家科技部"863"专项课题(2004AA07)
关键词 转甲状腺素蛋白 血压 体脂 胰岛素抵抗 transthyretin blood pressure body fat insulin sensitivity
  • 相关文献

参考文献9

  • 1Beck F K,Rosenthal T C. Prelbumin:a Marker for Nutritional Evaluation[J]. AM Faro Physician,2002,65(8): 1575-1578.
  • 2白晓苏,龚莉琳,张素华,李蓉,任伟,张闻宇,程庆丰.肥胖患者转甲状腺素蛋白水平的研究[J].第三军医大学学报,2007,29(10):970-972. 被引量:7
  • 3Nora K, Timothy E G,Janin B, et al. Serum Retinol-Binding Protein is More Highly Expressed in Visceral Than in Subcutaneous Adipose Tissue and Is a Marker of Intra-abdominal Fat Mags[J]. Cell Metab, 2007,6 (1) : 79-87.
  • 4陆泽元,林怿昊,邵豪,邹钢.非高血压人群血压与体脂和胰岛素抵抗相关[J].中华内分泌代谢杂志,2005,21(1):25-26. 被引量:19
  • 5Chobanian A V,Bakris G L,Black H R,et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation,and Treatment of High Blood Pressure[J]. JAMA, 2003,289 : 2560-2572.
  • 6Lim S,Choi S H,Jeong I K,et al. Insulin-sensitizing Effects of Exercise on Adiponectin and Retinol Binding Protein-4 Concentrations in Young and Middle-aged Women[J]. Clin Endocrinol Metab, 2008,93(6) :2263-2268.
  • 7Refai E, Dekki N, Yang S N, et al. Transthyretin Constitutes a Functional Component Pancreatic β-cell Stimulus-secretion Coupling[J]. Proc Natl Acad Sci, 2005,102(47) : 17020-17025.
  • 8Thomas GN, Critchley J A, Tomlinson B, et al. Obiesity, Independent of Insulin Resistance, Is a Major Determinant of Blood Pressure in Normoglycemic[J]. Hong Kong Chinese Metabolian, 2000,49 : 1523-1528.
  • 9包玉倩,贾伟平,陆俊茜,陈蕾,项坤三.中国人高血压个体胰岛素抵抗的影响因素[J].中华心血管病杂志,2002,30(8):483-486. 被引量:27

二级参考文献28

  • 1Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA, 2003,289:2560-2572.
  • 2McAuley KA, Williams SM, Mann JI, et al. Diagnosing insulin resistance in the general population. Diabetes Care, 2001,24:460-464.
  • 3Bonora E, Targher G, Alberiche M, et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity. Diabetes Care, 2000,23:57-63.
  • 4Laakso M. How good a marker is insulin level for insulin resistance? Am J Epidemiol, 1993,137:959-965.
  • 5Packard C, Caslake M, Shepherd J. The role of small, dense low density lipoprotein(LDL): a new look. Int J Cardiol, 2000,74(suppl):s17-22.
  • 6Ascaso JF, Pardo S, Real JT, et al. Diagnosing insulin resistance by simple quantitative methods in subjects with normal glucose metabolism. Diabetes Care, 2003,26:3320-3325.
  • 7Thomas GN, Critchley JA, Tomlinson B, et al. Obesity, independent of insulin resistance, is a major determinant of blood pressure in normoglycemic Hong Kong Chinese. Metabolism, 2000,49:1523-1528.
  • 8Haffner SM, Valdez RA, Hazuda HP, et al. Prospective analysis of the insulin-resistance syndrome (Syndrome X ). Diabetes, 1992,41: 715-722.
  • 9Salvetti A, Brogi G, Di-Legge V, et al. The inter-relationship between insulin resistance and hypertension. Drugs, 1993, 46 (Suppl): 2149-2159.
  • 10Bonora E, Kiechl S, Willeit J, et al. Prevalence of insulin resistance in metabolic disorders. The Bruneck study. Diabetes, 1998, 47: 1643- 1649.

共引文献50

同被引文献10

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部